FABP: A Potential Drug Target and Biomarker (P8222)

Target Name: Fatty Acid Binding Protein

NCBI ID: P8222

Fatty Acid Binding Protein

Other Name(s): FABP

FABP: A Potential Drug Target and Biomarker

Fatty Acid Binding Protein (FABP) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. FABP is a member of the transmembrane protein family, which means that it spans the cell membrane and is involved in various cellular processes. One of the functions of FABP is to bind to fatty acids, which are essential components of cell membranes.

FABP has been shown to play a role in the regulation of various cellular processes, including inflammation, fibrosis, and cancer. Its involvement in these processes has led to its potential as a drug target or biomarker.

One of the key benefits of FABP as a drug target is its ability to interact with a wide range of molecules, including small molecules, peptides, and proteins. This makes it a promising target for the development of new drugs that can modulate various cellular processes.

FABP has also been shown to be involved in the regulation of inflammation and fibrosis. Its involvement in these processes has led to its potential as a drug target for the treatment of various inflammatory and fibrotic diseases, including cancer, autoimmune diseases, and chronic obstructive pulmonary disease (COPD).

In addition to its potential as a drug target, FABP has also been shown to be a potential biomarker for various diseases. Its involvement in the regulation of cellular processes makes it a potential indicator of the health of cells, tissues, or organs. This has led to its potential as a diagnostic tool for various diseases, including cancer, neurodegenerative diseases, and cardiovascular disease.

Overall, FABP is a protein that has the potential to be a drug target or biomarker for a wide range of diseases. Its ability to interact with a wide range of molecules and its involvement in the regulation of various cellular processes make it an attractive target for the development of new drugs and diagnostic tools. Further research is needed to fully understand the role of FABP in disease and to develop effective treatments and diagnostic tools.

Protein Name: Fatty Acid Binding Protein (nonspecified Subtype)

The "Fatty Acid Binding Protein Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Fatty Acid Binding Protein comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets